Concepedia

Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer

Anthony J. Bazzan, George Zabrecky, Nancy Wintering, Andrew B. Newberg, Daniel Monti

Integrative Cancer Therapies · 2018 · 30 citations · 30 references

DOIFull text

Open access

Abstract

The results of this retrospective analysis support the growing evidence that IV AA is generally safe and well tolerated in patients with cancer, and may be useful in symptom management and improving quality of life.

References

30

Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues

Qi Chen, Michael Graham Espey, Murali C. Krishna et al. · Proceedings of the National Academy of Sciences · 2005 · 1.1K citations · Full text

Kidney stones: a global picture of prevalence, incidence, and associated risk factors.

Victoriano Romero, Haluk Akpınar, Dean G. Assimos · PubMed · 2010 · 996 citations

, , +16

Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use

Sebastian J. Padayatty, He Sun, Yaohui Wang et al. · Annals of Internal Medicine · 2004 · 953 citations

, , +13

High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy

Charles G. Moertel, Thomas R. Fleming, Edward T. Creagan et al. · New England Journal of Medicine · 1985 · 622 citations

Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer

Edward T. Creagan, Charles G. Moertel, Judith R. OʼFallon et al. · New England Journal of Medicine · 1979 · 576 citations

, , +12